Search

Displaying results 3251 - 3260 of 6076 in total
  1. Drug

    Phenserine

    go.drugbank.com/drugs/DB04892
    Investigational

    Phenserine is a next generation acetylcholinesterase (AChE) inhibitor indicated for the treatment of AD. … Phenserine is under development by Axonyx, a US biopharmaceutical company that focuses on treatments for dementia.

  2. Drug

    Acadesine

    go.drugbank.com/drugs/DB04944
    Investigational

    Acadesine has been granted Orphan Drug Designation for B-CLL in the EU. … Acadesine (AICA-riboside) is a purine nucleoside analog with anti-ischemic properties that is currently being studied (Phase 3) for the prevention of adverse cardiovascular outcomes in patients undergoing

  3. Drug

    ATX-201

    go.drugbank.com/drugs/DB05765
    Investigational

    It is developed by Kythera Biopharmaceuticals, Inc. for the treatment of actinic keratosis. The company announced the decision to discontinue its ATX-201 clinical program for actinic keratosis.

  4. Drug

    Enecadin

    go.drugbank.com/drugs/DB13032
    Investigational

    Enecadin has been investigated for the treatment of Stroke.

  5. Drug

    GW-870086

    go.drugbank.com/drugs/DB12322
    Investigational

    GW870086X has been investigated for the treatment of ASTHMA.

  6. Drug

    Ipamorelin

    go.drugbank.com/drugs/DB12370
    Investigational

    Ipamorelin has been investigated for the treatment of Ileus.

  7. Drug

    Modufolin

    go.drugbank.com/drugs/DB12676
    Investigational

    Modufolin is under investigation for the treatment of Osteosarcoma.

  8. Drug

    Vestipitant

    go.drugbank.com/drugs/DB11949
    Investigational

    Vestipitant has been investigated for the treatment of Tinnitus.

  9. Drug

    Recombinant alpha 1-antitrypsin

    go.drugbank.com/drugs/DB05481
    Investigational

    The proteinase/antiproteinase balance is believed to be important for maintaining healthy skin. The rAAT topical gel (Dermolastin™) is indicated for patients with atopic dermatitis and psoriasis. … The company has indicated that other formulations for gastroenterological and urological indications will also be developed.

  10. Drug

    MIV-701

    go.drugbank.com/drugs/DB05736
    Experimental

    It is developed for the treatment of osteoporosis.